The risk of QTc-interval prolongation in COVID-19 patients treated with chloroquine

被引：0
|
作者：
F. S. Sinkeler
F. A. Berger
H. J. Muntinga
M. M. P. M. Jansen
机构：
[1] Elisabeth-TweeSteden Hospital,Department of Clinical Pharmacy
[2] Elisabeth-TweeSteden Hospital,Department of Cardiology
[3] Meander Medical Centre,Department of Clinical Pharmacy
来源：
Netherlands Heart Journal | 2020年 / 28卷
关键词：
Chloroquine; COVID-19; Electrocardiography; QTc interval;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：418 / 423
页数：5
相关论文
共 50 条
  • [31] Is QTc-Interval Prolongation an Inherent Feature of Eating Disorders? A Cohort Study
    Krantz, Mori J.
    Blalock, Dan V.
    Tanganyika, Kundai
    Farasat, Morteza
    McBride, Jennifer
    Mehler, Philip S.
    [J]. AMERICAN JOURNAL OF MEDICINE, 2020, 133 (09): : 1088 - +
  • [32] Incidence and relevance of QTc-interval prolongation caused by tyrosine kinase inhibitors
    J S L Kloth
    A Pagani
    M C Verboom
    A Malovini
    C Napolitano
    W H J Kruit
    S Sleijfer
    N Steeghs
    A Zambelli
    R H J Mathijssen
    [J]. British Journal of Cancer, 2015, 112 : 1011 - 1016
  • [33] QT prolongation in a diverse, urban population of COVID-19 patients treated with hydroxychloroquine, chloroquine, or azithromycin
    Hsia, Brian C.
    Greige, Nicolas
    Quiroz, Jose A.
    Khokhar, Ahmed S.
    Daily, Johanna
    Di Biase, Luigi
    Ferrick, Kevin J.
    Fisher, John D.
    Krumerman, Andrew
    [J]. JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2020, 59 (02) : 337 - 345
  • [34] QT prolongation in a diverse, urban population of COVID-19 patients treated with hydroxychloroquine, chloroquine, or azithromycin
    Brian C Hsia
    Nicolas Greige
    Jose A Quiroz
    Ahmed S Khokhar
    Johanna Daily
    Luigi Di Biase
    Kevin J Ferrick
    John D Fisher
    Andrew Krumerman
    [J]. Journal of Interventional Cardiac Electrophysiology, 2020, 59 : 337 - 345
  • [35] QTc interval and electrocardiographic findings of COVID-19 patients Electrocardiographic findings of COVID-19 patients
    Ay, Mehmet Oguzhan
    Kozaci, Nalan
    Ay, Ozlem Oymak
    Kaya, Halil
    Bulut, Mehtap
    Yuksel, Melih
    Adali, Ebru
    Kenan, Enad
    Cetin, Ebru
    [J]. ANNALS OF CLINICAL AND ANALYTICAL MEDICINE, 2021, 12 (09): : 1031 - 1036
  • [36] Incidence and relevance of QTc-interval prolongation caused by tyrosine kinase inhibitors
    Kloth, J. S. L.
    Pagani, A.
    Verboom, M. C.
    Malovini, A.
    Napolitano, C.
    Kruit, W. H. J.
    Sleijfer, S.
    Steeghs, N.
    Zambelli, A.
    Mathijssen, R. H. J.
    [J]. BRITISH JOURNAL OF CANCER, 2015, 112 (06) : 1011 - 1016
  • [37] Incidence and determinants of QT interval prolongation in COVID-19 patients treated with hydroxychloroquine and azithromycin
    Maraj, Ilir
    Hummel, James P.
    Taoutel, Roy
    Chamoun, Romy
    Workman, Virginia
    Li, Cindy
    Tran, Lydia
    DelVecchio, Alexander
    Howes, Christopher
    Akar, Joseph G.
    [J]. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2020, 31 (08) : 1904 - 1907
  • [38] QTc prolongation during antiviral therapy in two COVID-19 patients
    Zhu, Suyan
    Wang, Jian
    Wang, Yong
    Chu, Jinguo
    Liu, Yao
    Chen, Xueqin
    Chen, Xiaomin
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2020, 45 (05) : 1190 - 1193
  • [39] Risk of QTC interval prolongation among cancer patients treated with tyrosine kinase inhibitors
    Abu Rmilah, A.
    Lin, G.
    Hermann, J.
    [J]. EUROPEAN HEART JOURNAL, 2019, 40 : 3586 - 3586
  • [40] Coronavirus disease 2019 (COVID-19) and QTc prolongation
    Changal, Khalid
    Paternite, David
    Mack, Sean
    Veria, Spiro
    Bashir, Rehana
    Patel, Mitra
    Soni, Ronak
    Ali, Muhammad
    Mir, Tanveer
    Sheikh, Mujeeb
    Ramanathan, P. Kasi
    [J]. BMC CARDIOVASCULAR DISORDERS, 2021, 21 (01)
12345